Back to results
US 6,107,494 AGranted
Substituted 5-aryl-benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
AssigneeG.D. Searle & Co.
InventorsLen F. Lee, Shyamal C. Banerjee, Horng-Chih Huang, Jinglin J. Li, Raymond E. Miller, David B. Reitz, Samuel J. Tremont
Life of this patent
Estimating the term…
Abstract
Provided are novel benzothiepines, derivatives, and analogs thereof; pharmaceutical compositions containing them; and methods of using these compounds and compositions in medicine, particularly in the prophylaxis and treatment of hyperlipidemic conditions such as those associated with atherosclerosis or hypercholesterolemia, in mammals.
Claims19
A compound of formula (I):
- wherein:
- q is an integer from 1 to 4;
- n is 2;
- R.sup.1 and R.sup.2 are independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, haloalkyl, alkylaryl, arylalkyl, alkoxy, alkoxyalkyl, dialkylamino, alkylthio, (polyalkyl)aryl, and cycloalkyl,
- wherein alkyl, alkenyl, alkynyl, haloalkyl, alkylaryl, arylalkyl, alkoxy, alkoxyalkyl, dialkylamino, alkylthio, (polyalkyl)aryl, and cycloalkyl optionally are substituted with one or more substituents selected from the group consisting of OR.sup.9, NR.sup.9 R.sup.10, N.sup.+ R.sup.9 R.sup.10 R.sup.w A.sup.-, SR.sup.9, SR.sup.+ R.sup.9 R.sup.10 A.sup.-. P.sup.+ R.sup.9 R.sup.10 R.sup.11 A.sup.-, S(O)R.sup.9, SO.sub.2 R.sup.9, SO.sub.3 R.sup.9, CO.sub.2 R.sup.9, CN, halogen, oxo, and CONR.sup.9 R.sup.10,
- wherein alkyl, alkenyl, alkynyl, alkylaryl, alkoxy, alkoxyalkyl, (polyalkyl)aryl, and cycloalkyl optionally have one or more carbons replaced by O, NR.sup.9, N.sup.+ R.sup.9 R.sup.10 A-, S, SO, SO.sub.2, S.sup.+ R.sup.9 A.sup.-, P.sup.+ R.sup.9 R.sup.10 A.sup.-, or phenylene,
- wherein R.sup.9, R.sup.10, and R.sup.w are independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, acyl, heterocycle, ammoniumalkyl, arylalkyl, and alkylammoniumalkyl;
- or
- R.sup.1 and R.sup.2 taken together with the carbon to which they are attached form C.sub.3 -C.sub.10 cycloalkyl;
- R.sup.3 and R.sup.4 are independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, acyloxy, aryl, heterocycle, OR.sup.9, NR.sup.9 R.sup.10, SR.sup.9, S(O)R.sup.9, SO.sub.2 R.sup.9, and SO.sub.3 R.sup.9, wherein R.sup.9 and R.sup.10 are as defined above;
- or
- R.sup.3 and R.sup.4 together form .dbd.O, .dbd.NOR.sup.11, .dbd.S, .dbd.NNR.sup.11 R.sup.12, .dbd.NR.sup.9, or .dbd.CR.sup.11 R.sup.12,
- wherein R.sup.11 and R.sup.12 are independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, aryl, arylalkyl, alkenylalkyl, alkynylalkyl, heterocycle, carboxyalkyl, carboalkoxyalkyl, cycloalkyl, cyanoalkyl, OR.sup.9, NR.sup.9 R.sup.10, SR.sup.9, S(O)R.sup.9, SO.sub.2 R.sup.9, SO.sub.3 R.sup.9, CO.sub.2 R.sup.9, CN, halogen, oxo, and CONR.sup.9 R.sup.10, wherein R.sup.9 and R.sup.10 are as defined above, provided that both R.sup.3 and R.sup.4 cannot be OH, NH.sub.2, and SH, or
- R.sup.11 and R.sup.12 together with the nitrogen or carbon atom to which they are attached form a cyclic ring;
- R.sup.5 is substituted aryl,
- wherein aryl is substituted with one or more substituent groups independently selected from the group consisting of alkyl, alkenyl, alkynyl, polyalkyl, polyether, aryl, haloalkyl, cycloalkyl, heterocycle, arylalkyl, quaternary heterocycle, quaternary heteroaryl, halogen, oxo, OR.sup.13, NR.sup.13 R.sup.14, SR.sup.13, S(O)R.sup.13, SO.sub.2 R.sup.13, SO.sub.3 R.sup.13, NR.sup.13 OR.sup.14, NR.sup.13 NR.sup.14 R.sup.15, NO.sub.2, CO.sub.2 R.sup.13, CN, OM, SO.sub.2 OM, SO.sub.2 NR.sup.13 R.sup.14, C(O)NR.sup.13 R.sup.14, C(O)OM, COR.sup.13, P(O)R.sup.13 R.sup.14, P.sup.+ R.sup.13 R.sup.14 R.sup.15 A.sup.-, P(OR.sup.13)OR.sup.14, S.sup.+ R.sup.13 R.sup.14 A.sup.-, and N.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-,
- wherein:
- A.sup.- is a pharmaceutically acceptable anion and M is a pharmaceutically acceptable cation,
- said alkyl, alkenyl, alkynyl, polyalkyl, polyether, aryl, haloalkyl, cycloalkyl, and heterocycle can be further substituted with one or more substituent groups selected from the group consisting of OR.sup.7, NR.sup.7 R.sup.8, SR.sup.7, S(O)R.sup.7, SO.sub.2 R.sup.7, SO.sub.3 R.sup.7, CO.sub.2 R.sup.7, CN, oxo, CONR.sup.7 R.sup.8, N.sup.+ R.sup.7 R.sup.8 R.sup.9 A-, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycle, arylalkyl, quaternary heterocycle, quaternary heteroaryl, P(O)R.sup.7 R.sup.8, P.sup.+ R.sup.7 R.sup.8 R.sup.9 A.sup.-, and P(O)(OR.sup.7)OR.sup.8, and
- wherein said alkyl, alkenyl, alkynyl, polyalkyl, polyether, aryl, haloalkyl, cycloalkyl, and heterocycle can optionally have one or more carbons replaced by O, NR.sup.7, N.sup.+ R.sup.7 R.sup.8 A-, S, SO, SO.sub.2, S.sup.+ R.sup.7 A-, PR.sup.7, P(O)R.sup.7, P.sup.+ R.sup.7 R.sup.8 A-, or phenylene, and R.sup.13, R.sup.14, and R.sup.15 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, polyalkyl, aryl, arylalkyl, cycloalkyl, heterocycle, heteroaryl, quaternary heterocycle, quaternary heteroaryl, and quaternary heteroarylalkyl,
- wherein alkyl, alkenyl, alkynyl, arylalkyl, heterocycle, and polyalkyl optionally have one or more carbons replaced by O, NR.sup.9, N.sup.+ R.sup.9 R.sup.10 A-, S, SO, SO.sub.2, S.sup.+ R.sup.9 A.sup.-, PR.sup.9, P.sup.+ R.sup.9 R.sup.10 A-, P(O)R.sup.9, phenylene, carbohydrate, amino acid, peptide, or polypeptide, and
- R.sup.13, R.sup.14, and R.sup.15 are optionally substituted with one or more groups selected from the group consisting of sulfoalkyl, quaternary heterocycle, quaternary heteroaryl, OR.sup.9, NR.sup.9 R.sup.10, N.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-, SR.sup.9, S(O)R.sup.9, SO.sub.2 R.sup.9, SO.sub.3 R.sup.9, oxo, CO.sub.2 R.sup.9, CN, halogen, CONR.sup.9 R.sup.10, SO.sub.2 OM, SO.sub.2 NR.sup.9 R.sup.10, PO(OR.sup.16)OR.sup.17, P.sup.+ R.sup.9 R.sup.10 R.sup.11 A-, S.sup.+ R.sup.9 R.sup.10 A-, and C(O)OM,
- wherein R.sup.16 and R.sup.17 are independently selected from the substituents constituting R.sup.9 and M;
- or
- R.sup.14 and R.sup.15, together with the nitrogen atom to which they are attached, form a cyclic ring;
- and
- R.sup.6 is hydrogen;
- R.sup.7 and R.sup.8 are independently selected from the group consisting of hydrogen and alkyl;
- and
- one or more R.sup.x are independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, polyalkyl, acyloxy, aryl, arylalkyl, halogen, haloalkyl, cycloalkyl, heterocycle, heteroaryl, polyether, quaternary heterocycle, quaternary heteroaryl, OR.sup.13, NR.sup.13 R.sup.14, SR.sup.13, S(O)R.sup.13, S(O).sub.2 R.sup.13, SO.sub.3 R.sup.13, S.sup.+ R.sup.13 R.sup.14 A-, NR.sup.13 OR.sup.14, NR.sup.13 NR.sup.14 R.sup.15, NO.sub.2, CO.sub.2 R.sup.13, CN, OM, SO.sub.2 OM, SO.sub.2 NR.sup.13 R.sup.14, NR.sup.14 C(O)R.sup.13, C(O)NR.sup.13 R.sup.14, NR14C(O)R13, C(O)OM, COR.sup.13, OR.sup.18, S(O).sub.n NR.sup.18, NR.sup.13 R.sup.18, NR.sup.18 OR.sup.14, N.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-, P.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-, amino acid, peptide, polypeptide, and carbohydrate,
- wherein alkyl, alkenyl, alkynyl, cycloalkyl, aryl, polyalkyl, heterocycle, acyloxy, arylalkyl, haloalkyl, polyether, quaternary heterocycle, and quaternary heteroaryl can be further substituted with OR.sup.9, NR.sup.9 R.sup.10, N.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-, SR.sup.9, S(O)R.sup.9, SO.sub.2 R.sup.9, SO.sub.3 R.sup.9, oxo, CO.sub.2 R.sup.9, CN, halogen, CONR.sup.9 R.sup.10, SO.sub.2 OM, SO.sub.2 NR.sup.9 R.sup.10, PO(OR.sup.16)OR.sup.17, P.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-, S.sup.+ R.sup.9 R.sup.10 A.sup.-, or C(O)OM, and
- wherein R.sup.18 is selected from the group consisting of acyl, arylalkoxycarbonyl, arylalkyl, heterocycle, heteroaryl, alkyl,
- wherein acyl, arylalkoxycarbonyl, arylalkyl, heterocycle, heteroaryl, alkyl, quaternary heterocycle, and quaternary heteroaryl optionally are substituted with one or more substituents selected from the group consisting of OR.sup.9, NR.sup.9 R.sup.10, N.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-, SR.sup.9, S(O)R.sup.9, SO.sub.2 R.sup.9, SO.sub.3 R.sup.9, oxo, CO.sub.2 R.sup.9, CN, halogen, CONR.sup.9 R.sup.10, SO.sub.3 R.sup.9, SO.sub.2 OM, SO.sub.2 NR.sup.9 R.sup.10, PO(OR.sup.16)OR.sup.17, and C(O)OM,
- wherein in R.sup.x, one or more carbons are optionally replaced by O, NR.sup.13, N.sup.+ R.sup.13 R.sup.14 A-, S, SO, SO.sub.2, S.sup.+ R.sup.13 A.sup.-, PR.sup.13, P(O)R.sup.13, P.sup.+ R.sup.13 R.sup.14 A-, phenylene, amino acid, peptide, polypeptide, carbohydrate, polyether, or polyalkyl,
- wherein in said polyalkyl, phenylene, amino acid, peptide, polypeptide, and carbohydrate, one or more carbons are optionally replaced by O, NR.sup.9, N.sup.+ R.sup.9 R.sup.10 A.sup.-, S, SO, SO.sub.2, S.sup.+ R.sup.9 A-, PR.sup.9, P.sup.+ R.sup.9 R.sup.10 A-, or P(O)R.sup.9 ;
- wherein quaternary heterocycle and quaternary heteroaryl are optionally substituted with one or more groups selected from the group consisting of alkyl, alkenyl, alkynyl, polyalkyl, polyether, aryl, haloalkyl, cycloalkyl, heterocycle, arylalkyl, halogen, oxo, OR.sup.13, NR.sup.13 R.sup.14, SR.sup.13, S(O)R.sup.13, SO.sub.2 R.sup.13, SO.sub.3 R.sup.13, NR.sup.13 OR.sup.14, NR.sup.13 NR.sup.14 R.sup.15, NO.sub.2, CO.sub.2 R.sup.13, CN, OM, SO.sub.2 OM, SO.sub.2 NR.sup.13 R.sup.14, C(O)NR.sup.13 R.sup.14, C(O)OM, COR.sup.13, P(O)R.sup.13 R.sup.14, P.sup.+ R.sup.13 R.sup.14 R.sup.15 A.sup.-, P(OR.sup.13)OR.sup.14, S.sup.+ R.sup.13 R.sup.14 A.sup.-, and N.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-,
- provided that when R.sup.5 or R.sup.6 is phenyl, only one of R.sup.1 or R.sup.2 is H;
- provided that when q=1 and R.sup.x is styryl, anilido, or anilinocarbonyl, only one of R.sup.5 or R.sup.6 is alkyl;
- or
- a pharmaceutically acceptable salt, solvate, or prodrug thereof.
37 more elements
A compound of formula (I):
- ##STR555## wherein:
- q is an integer from 1 to 4;
- n is 2;
- R.sup.1 and R.sup.2 are independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, haloalkyl, alkylaryl, arylalkyl, alkoxy, alkoxyalkyl, dialkylamino, alkylthio, (polyalkyl)aryl, and cycloalkyl,
- wherein alkyl, alkenyl, alkynyl, haloalkyl, alkylaryl, arylalkyl, alkoxy, alkoxyalkyl, dialkylamino, alkylthio, (polyalkyl)aryl, and cycloalkyl optionally are substituted with one or more substituents selected from the group consisting of OR.sup.9, NR.sup.9 R.sup.10, N.sup.+ R.sup.9 R.sup.10 R.sup.w A.sup.-, SR.sup.9, S.sup.+ R.sup.9 R.sup.10 A.sup.-. P.sup.+ R.sup.9 R.sup.10 R.sup.11 A.sup.-, S(O)R.sup.9, SO.sub.2 R.sup.9, SO.sub.3 R.sup.9, CO.sub.2 R.sup.9, CN, halogen, oxo, and CONR.sup.9 R.sup.10,
- wherein alkyl, alkenyl, alkynyl, alkylaryl, alkoxy, alkoxyalkyl, (polyalkyl)aryl, and cycloalkyl optionally have one or more carbons replaced by O, NR.sup.9, N.sup.+ R.sup.9 R.sup.10 A-, S, SO, SO.sub.2, S.sup.+ R.sup.9 A.sup.-, P.sup.+ R.sup.9 R.sup.10 A.sup.-, or phenylene,
- wherein R.sup.9, R.sup.10, and R.sup.w are independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, acyl, heterocycle, ammoniumalkyl, arylalkyl, carboxyalkyl, carboxyheteroaryl, carboxyheterocycle, carboalkoxyalkyl, carboxyalkylamino, heteroarylalkyl, heterocyclylalkyl, and alkylammoniumalkyl;
- or
- R.sup.1 and R.sup.2 taken together with the carbon to which they are attached form C.sub.3 -C.sub.10 cycloalkyl;
- R.sup.3 and R.sup.4 are independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, acyloxy, aryl, heterocycle, OR.sup.9, NR.sup.9 R.sup.10, SR.sup.9, S(O)R.sup.9, SO.sub.2 R.sup.9, and SO.sub.3 R.sup.9, wherein R.sup.9 and R.sup.10 are as defined above;
- or
- R.sup.3 and R.sup.4 together form .dbd.O, .dbd.NOR.sup.11, .dbd.S, .dbd.NNR.sup.11 R.sup.12, .dbd.NR.sup.9, or .dbd.CR.sup.11 R.sup.12,
- wherein R.sup.11 and R.sup.12 are independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, aryl, arylalkyl, alkenylalkyl, alkynylalkyl, heterocycle, carboxyalkyl, carboalkoxyalkyl, cycloalkyl, cyanoalkyl, OR.sup.9, NR.sup.9 R.sup.10, SR.sup.9, S(O)R.sup.9, SO.sub.2 R.sup.9, SO.sub.3 R.sup.9, CO.sub.2 R.sup.9, CN, halogen, oxo, and CONR.sup.9 R.sup.10, wherein R.sup.9 and R.sup.10 are as defined above, provided that both R.sup.3 and R.sup.4 cannot be OH, NH.sub.2, and SH, or
- R.sup.11 and R.sup.12 together with the nitrogen or carbon atom to which they are attached form a cyclic ring;
- R.sup.5 is aryl substituted with one or more substituent groups independently selected from the group consisting of NR.sup.13 C(O)R.sup.14, NR.sup.13 C(O)NR.sup.14 R.sup.15, NR.sup.13 CO.sub.2 R.sup.14, OC(O)R.sup.13, OC(O)NR.sup.13 R.sup.14, NR.sup.13 SOR.sup.14, NR.sup.13 SOR.sup.14, NR.sup.13 SO.sub.2 R.sup.14, NR.sup.13 SONR.sup.14 R.sup.15, and NR.sup.13 SO.sub.2 NR.sup.14 R.sup.15,
- wherein:
- R.sup.13, R.sup.14, and R.sup.15 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, polyalkyl, polyether, aryl, arylalkyl, alkylarylalkyl, alkylheteroarylalkyl, alkylheterocyclylalkyl, cycloalkyl, heterocycle, heteroaryl, quaternary heterocycle, quaternary heteroaryl, heterocyclylalkyl, heteroarylalkyl, quaternary heterocyclylalkyl, quaternary heteroarylalkyl, alkylammoniumalkyl, and carboxyalkylaminocarbonylalkyl,
- R.sup.13, R.sup.14, and R.sup.15 are optionally substituted with one or more groups selected from the group consisting of hydroxy, amino, sulfo, carboxy, alkyl, carboxyalkyl, heterocycle, heteroaryl, sulfoalkyl, quaternary heterocycle, quaternary heteroaryl, quaternary heterocyclylalkyl, quaternary heteroarylalkyl, guanidinyl, OR.sup.9, NR.sup.9 R.sup.10, N.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-, SR.sup.9, S(O)R.sup.9, SO.sub.2 R.sup.9, SO.sub.3 R.sup.9, oxo, CO.sub.2 R.sup.9, CN, halogen, CONR.sup.9 R.sup.10, SO.sub.2 OM, SO.sub.2 NR.sup.9 R.sup.10, PO(OR.sup.16)OR.sup.17, P.sup.+ R.sup.9 R.sup.10 R.sup.11 A-, S.sup.+ R.sup.9 R.sup.10 A-, and C(O)OM,
- wherein A.sup.- is an pharmaceutically acceptable anion and M is a pharmaceutically acceptable cation,
- wherein R.sup.16 and R.sup.17 are independently selected from the substituents constituting R.sup.9 and M;
- or
- R.sup.13 and R.sup.14, together with the nitrogen atom to which they are attached form a mono- or polycyclic heterocycle that is optionally substituted with one or more radicals selected from the group consisting of oxo, carboxy and quaternary salts;
- or
- R.sup.14 and R.sup.15, together with the nitrogen atom to which they are attached, form a cyclic ring;
- and
- R.sup.6 is hydrogen;
- R.sup.7 and R.sup.8 are independently selected from the group consisting of hydrogen and alkyl;
- and
- one or more R.sup.x are independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, polyalkyl, acyloxy, aryl, arylalkyl, halogen, haloalkyl, cycloalkyl, heterocycle, heteroaryl, polyether, quaternary heterocycle, quaternary heteroaryl, OR.sup.13, NR.sup.13 R.sup.14, SR.sup.13, S(O)R.sup.13, S(O).sub.2 R.sup.13, SO.sub.3 R.sup.13, S.sup.+ R.sup.13 R.sup.14 A-, NR.sup.13 OR.sup.14, NR.sup.13 NR.sup.14 R.sup.15, NO.sub.2, CO.sub.2 R.sup.13, CN, OM, SO.sub.2 OM, SO.sub.2 NR.sup.13 R.sup.14, NR.sup.14 C(O)R.sup.13, C(O)NR.sup.13 R.sup.14, NR14C(O)R13, C(O)OM, COR.sup.13, OR.sup.18, S(O).sub.n NR.sup.18, NR.sup.13 R.sup.18, NR.sup.18 OR.sup.14, N.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-, P.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-, amino acid, peptide, polypeptide, and carbohydrate,
- wherein alkyl, alkenyl, alkynyl, cycloalkyl, aryl, polyalkyl, heterocycle, acyloxy, arylalkyl, haloalkyl, polyether, quaternary heterocycle, and quaternary heteroaryl can be further substituted with OR.sup.9, NR.sup.9 R.sup.10, N.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-, SR.sup.9, S(O)R.sup.9, SO.sub.2 R.sup.9, SO.sub.3 R.sup.9, oxo, CO.sub.2 R.sup.9, CN, halogen, CONR.sup.9 R.sup.10, SO.sub.2 OM, SO.sub.2 NR.sup.9 R.sup.10, PO(OR.sup.16)OR.sup.17, P.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-, S.sup.+ R.sup.9 R.sup.10 A.sup.-, or C(O)OM, and
- wherein R.sup.18 is selected from the group consisting of acyl, arylalkoxycarbonyl, arylalkyl, heterocycle, heteroaryl, alkyl,
- wherein acyl, arylalkoxycarbonyl, arylalkyl, heterocycle, heteroaryl, alkyl, quaternary heterocycle, and quaternary heteroaryl optionally are substituted with one or more substituents selected from the group consisting of OR.sup.9, NR.sup.9 R.sup.10, N.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-, SR.sup.9, S(O)R.sup.9, SO.sub.2 R.sup.9, SO.sub.3 R.sup.9, oxo, CO.sub.2 R.sup.9, CN, halogen, CONR.sup.9 R.sup.10, SO.sub.3 R.sup.9, SO.sub.2 OM, SO.sub.2 NR.sup.9 R.sup.10, PO(OR.sup.16)OR.sup.17, and C(O)OM,
- wherein in R.sup.x, one or more carbons are optionally replaced by O, NR.sup.13, N.sup.+ R.sup.13 R.sup.14 A-, S, SO, SO.sub.2, S.sup.+ R.sup.13 A.sup.-, PR.sup.13, P(O)R.sup.13, P.sup.+ R.sup.13 R.sup.14 A-, phenylene, amino acid, peptide, polypeptide, carbohydrate, polyether, or polyalkyl,
- wherein in said polyalkyl, phenylene, amino acid, peptide, polypeptide, and carbohydrate, one or more carbons are optionally replaced by O, NR.sup.9, N.sup.+ R.sup.9 R.sup.10 A.sup.-, S, SO, SO.sub.2, S.sup.+ R.sup.9 A-, PR.sup.9, P.sup.+ R.sup.9 R.sup.10 A-, or P(O)R.sup.9 ;
- wherein quaternary heterocycle and quaternary heteroaryl are optionally substituted with one or more groups selected from the group consisting of alkyl, alkenyl, alkynyl, polyalkyl, polyether, aryl, haloalkyl, cycloalkyl, heterocycle, arylalkyl, halogen, oxo, OR.sup.13, NR.sup.13 R.sup.14, SR.sup.13, S(O)R.sup.13, SO.sub.2 R.sup.13, SO.sub.3 R.sup.13, NR.sup.13 OR.sup.14, NR.sup.13 NR.sup.14 R.sup.15, NO.sub.2, CO.sub.2 R.sup.13, CN, OM, SO.sub.2 OM, SO.sub.2 NR.sup.13 R.sup.14, C(O)NR.sup.13 R.sup.14, C(O)OM, COR.sup.13, P(O)R.sup.13 R.sup.14, P.sup.+ R.sup.13 R.sup.14 R.sup.15 A.sup.-, P(OR.sup.13)OR.sup.14, S.sup.+ R.sup.13 R.sup.14 A.sup.-, and N.sup.+ R.sup.9 R.sup.11 R.sup.12 A.sup.-, or
- a pharmaceutically acceptable salt, solvate, or prodrug thereof.
33 more elements
Dependencies are inferred from the claim text.